These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 17633224)
41. Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11. Powell PK; Wolf I; Jin R; Lasker JM J Pharmacol Exp Ther; 1998 Jun; 285(3):1327-36. PubMed ID: 9618440 [TBL] [Abstract][Full Text] [Related]
42. [Roles of 20-HETE on physiologic and pathologic regulation in organism]. Zhang D; Huo HL; Zhang YN; Zeng QH Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):120-4. PubMed ID: 17633224 [TBL] [Abstract][Full Text] [Related]
43. [Progress of studies in 20-hydroxyeicosatetraenoic acid on vascular endothelium]. Li H; Zhu Y Sheng Li Ke Xue Jin Zhan; 2013 Feb; 44(1):1-5. PubMed ID: 23671992 [TBL] [Abstract][Full Text] [Related]
44. Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system. Miyata N; Roman RJ J Smooth Muscle Res; 2005 Aug; 41(4):175-93. PubMed ID: 16258232 [TBL] [Abstract][Full Text] [Related]
45. P-450 metabolites of arachidonic acid in the control of cardiovascular function. Roman RJ Physiol Rev; 2002 Jan; 82(1):131-85. PubMed ID: 11773611 [TBL] [Abstract][Full Text] [Related]
46. 20-HETE in neovascularization. Chen L; Ackerman R; Guo AM Prostaglandins Other Lipid Mediat; 2012 Aug; 98(3-4):63-8. PubMed ID: 22227460 [TBL] [Abstract][Full Text] [Related]
47. 20-hydroxyeicosatetraenoic acid, endothelial dysfunction and hypertension. Pat Kunert M; Drenjancević I Med Glas (Zenica); 2011 Aug; 8(2):170-80. PubMed ID: 21849935 [TBL] [Abstract][Full Text] [Related]
48. Conflicting roles of 20-HETE in hypertension and renal end organ damage. Zhang C; Booz GW; Yu Q; He X; Wang S; Fan F Eur J Pharmacol; 2018 Aug; 833():190-200. PubMed ID: 29886242 [TBL] [Abstract][Full Text] [Related]
49. Role of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids in hypertension. Sarkis A; Lopez B; Roman RJ Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):205-14. PubMed ID: 15202615 [TBL] [Abstract][Full Text] [Related]
50. Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology. Fan F; Ge Y; Lv W; Elliott MR; Muroya Y; Hirata T; Booz GW; Roman RJ Front Biosci (Landmark Ed); 2016 Jun; 21(7):1427-63. PubMed ID: 27100515 [TBL] [Abstract][Full Text] [Related]
51. Pressure-induced myogenic tone and role of 20-HETE in mediating autoregulation of cerebral blood flow. Harder DR; Narayanan J; Gebremedhin D Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1557-65. PubMed ID: 21257913 [TBL] [Abstract][Full Text] [Related]
52. Recent developments on the vascular effects of 20-hydroxyeicosatetraenoic acid. Garcia V; Schwartzman ML Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):74-82. PubMed ID: 27906746 [TBL] [Abstract][Full Text] [Related]
53. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Moreno JJ Biochem Pharmacol; 2009 Jan; 77(1):1-10. PubMed ID: 18761324 [TBL] [Abstract][Full Text] [Related]
54. 20-HETE in the regulation of vascular and cardiac function. Rocic P; Schwartzman ML Pharmacol Ther; 2018 Dec; 192():74-87. PubMed ID: 30048707 [TBL] [Abstract][Full Text] [Related]
55. 20-hydroxyeicosatetraeonic acid: a new target for the treatment of hypertension. Williams JM; Murphy S; Burke M; Roman RJ J Cardiovasc Pharmacol; 2010 Oct; 56(4):336-44. PubMed ID: 20930591 [TBL] [Abstract][Full Text] [Related]